DZ Bank’s Gilead Sciences GILD Stock Holding History

DZ Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-90,000	Closed	-$6.7M	–	820
2020 Q1	$6.7M	Buy	+90,000	New	+$6.22M	0.02%	286
2017 Q3	–	Sell	-100	Closed	-$7K	–	891
2017 Q2	$7K	Buy	+100	New	+$6.65K	﹤0.01%	914

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DZ Bank's GILD Position: Q2 2026 in Review

DZ Bank increased its Gilead Sciences (GILD) stake by 24% in Q2 2026, buying an estimated $66.6M and bringing the position to 2,628,110 shares worth $332M. The position accounts for 0.25% of the portfolio, ranked #93.

DZ Bank first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. 2,293 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

DZ Bank held 2,628,110 shares of Gilead Sciences worth $332M as of Q2 2026.
DZ Bank bought 505,131 Gilead Sciences shares in Q2 2026, an estimated $66.6M.
Gilead Sciences made up 0.25% of DZ Bank's portfolio in Q2 2026, its #93 holding.
DZ Bank first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
2,293 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.